Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $12.11M.
ENTERPRISE VALUE (EV)
$12.11M
Lipocine Inc.
Market Cap
$17.31M
Enterprise Value (EV)
$12.11M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Lipocine Inc. (LPCN) | $17.31M | $12.11M |
| Cosmos Health Inc. (COSM)vs › | $17.39M | $31.57M |
| Marker Therapeutics, Inc. (MRKR)vs › | $16.84M | $5.51M |
| TScan Therapeutics, Inc. (TCRX)vs › | $16.82M | $7.56M |
| Palatin Technologies, Inc. (PTN)vs › | $16.74M | $9.47M |
| PAVmed Inc. (PAVM)vs › | $16.72M | $30.01M |
| Bionano Genomics, Inc. (BNGO)vs › | $16.64M | $19.61M |
| Dyadic International, Inc. (DYAI)vs › | $16.52M | $20.14M |
| P3 Health Partners Inc. (PIII)vs › | $18.15M | $127.15M |
| Estrella Immunopharma, Inc. (ESLA)vs › | $18.30M | $18.16M |
Market Cap
$17.31M
Total Debt
$0.00
Cash
$5.21M
Enterprise Value
$12.11M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
